NCT06922409

Brief Summary

Background: Light is the most important regulator of circadian rhythm. Naturalistic light, which contains the spectrum of sunlight throughout the day, has been shown to have a positive impact on mental states such as depression and fatigue in stroke and other diseases requiring long-term hospitalization. Depression and fatigue are very common complications after stroke, with a frequency of 30% and 85%, respectively. Both are significantly related to reduced quality of life and early death. Both the causes and pathophysiology behind these complications are unknown, but it is assumed that disturbances (inflammation and cell death) in brain areas and brain networks related to arousal, sleep, circadian rhythm, and the frontal lobe play a role. The hypothesis is that it is possible to detect changes in brain networks related to depression and fatigue by MRI, and that naturalistic light will affect these changes. Method: Stroke patients requiring a minimum of 10 days of rehabilitation are transferred to a neurorehabilitation unit with naturalistic lighting. Examination: Validated tests for fatigue, depression, sleep and cognitive functions. Pathophysiological studies:

  • MRI focusing on cerebral blood flow, metabolism, and cerebral networks.
  • Spinal fluid analyses for hormones and markers involved in immunological response as well as wakefulness/arousal and depression.
  • Sleep assessments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
45mo left

Started Apr 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Apr 2025Jan 2030

First Submitted

Initial submission to the registry

March 27, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 10, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Expected
Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

March 27, 2025

Last Update Submit

April 10, 2025

Conditions

Keywords

circadian rhythm disruptionStrokePost Stroke DepressionPost Stroke FatigueLight therapyCircadian Light

Outcome Measures

Primary Outcomes (1)

  • Fatigue and depression

    Primary hypothesis: Naturalistic light reduce the major depression inventory questionnaire score and multidimensional fatigue inventory questionnaire score from baseline til discharge. Mood-related network will too show positive changes measured by whole brain resting-state connectivity in post-stroke patients compared with a control group without fatigue and depression.

    From admission at the rehabilitation unit to the time of discharge aprox. 10 days.

Secondary Outcomes (4)

  • Cognitive function

    From admission to the neurorehabilitation unit to the time of discharge aprox 10 days..

  • Sleep quality

    From admission to the neurorehabilitation unit to the time of discharge aprox. 10 days..

  • Hypocretin

    From admission to the neurorehabilitation unit to the time of discharge aprox. 10 days..

  • CFS inflammation

    From admission to the neurorehabilitation unit to the time of discharge aprox. 10 days.

Study Arms (2)

Moderate-severe depression or/and fatigue

ACTIVE COMPARATOR

Naturalistic Light Intervention

Device: Naturalistic Light Intervention

No measured depression or/and fatigue

ACTIVE COMPARATOR

Naturalistic Light Intervention

Device: Naturalistic Light Intervention

Interventions

Naturalistic light as an Intervention A 24-hour naturalistic lighting scheme is implemented in all areas and rooms in the unit at Rigshospitalet Glostrup with a computer-controlled lighting scheme (ChromaViso, Denmark). The naturalistic lighting scheme is constantly running. The lighting imitate the sunlight rhythm following the principles of Lucas et al.

Also known as: Circadiain Light Intervention, Dynamic Light Intervention
Moderate-severe depression or/and fatigueNo measured depression or/and fatigue

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scoring moderate-severe fatigue and/or depression OR NO fatigue and/or depressione which are evaluated as candidates for the rehabilitation unit.

You may not qualify if:

  • GCS \< 15
  • No functioning nervus opticus or retina in both eyes
  • Unable to open both eyes
  • Non communicating patients e.g. severe aphasia (incompetent patients)
  • Unable to cooperate to the physical examinations
  • Less than 10 days of hospitalization in the rehabilitation department
  • Claustrophobia
  • If the sub investigator finds the study participant unfit to conduct the investigations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health and Medical Sciences - University of Copenhagen

Glostrup Municipality, Capital Region, 2600, Denmark

RECRUITING

Related Publications (1)

  • West A, Jennum P, Simonsen SA, Sander B, Pavlova M, Iversen HK. Impact of naturalistic lighting on hospitalized stroke patients in a rehabilitation unit: Design and measurement. Chronobiol Int. 2017;34(6):687-697. doi: 10.1080/07420528.2017.1314300. Epub 2017 Apr 21.

    PMID: 28430522BACKGROUND

MeSH Terms

Conditions

Chronobiology DisordersStroke

Condition Hierarchy (Ancestors)

Nervous System DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Anders Sode West, MD, PhD

    Glostrup University Hospital, Copenhagen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anders Sode West, MD, PhD.

CONTACT

Helle Iversen, MD, D.M.Sc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Study Design: Case-control study Study description: Patients admitted at the acute stroke unit will be screened for fatigue and depression. The patients will be selected for the study by the present and absent of moderate-severe depression and fatigue (50%+50%). The control group will be patients without any symptoms of depression and fatigue. The intervention group will be patients scored to have moderate-severe depression and fatigue. All patients must be selected to neurorehabilitation for a minimum of 10 days where the intervention (naturalistic light) is installed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Ph.D. Principal Investigator

Study Record Dates

First Submitted

March 27, 2025

First Posted

April 10, 2025

Study Start

April 10, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

January 1, 2030

Last Updated

April 15, 2025

Record last verified: 2025-04

Locations